ShangHai HaiHe Pharmaceutical   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Shanghai China (2018)

Organization Overview

First Clinical Trial
2018
NCT01832298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Haihe Biopharma | Haihe Biopharma Co., Ltd. | ShangHai HaiHe Pharmaceutical